Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?
Immunotherapy has changed the treatment paradigm in multiple solid and hematologic malignancies. However, response remains limited in a significant number of cases, with tumors developing innate or acquired resistance to checkpoint inhibition. Certain “hot” or “immune-sensitive” tumors become “cold”...
Main Authors: | Rola El Sayed, Yolla Haibe, Ghid Amhaz, Youssef Bouferraa, Ali Shamseddine |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/4/2142 |
Similar Items
-
From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade
by: Ali H. Abdel Sater, et al.
Published: (2022-05-01) -
Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review
by: Yolla Haibe, et al.
Published: (2020-08-01) -
The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges
by: Youssef Bouferraa, et al.
Published: (2021-07-01) -
The Cellular Respiration of Endometrial Biopsies from Patients with Various Forms of Endometriosis
by: Konstantin A. Toniyan, et al.
Published: (2024-03-01) -
Differential Kat3 Usage Orchestrates the Integration of Cellular Metabolism with Differentiation
by: Xiaohui Hu, et al.
Published: (2021-11-01)